1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cystic fibrosis

Vanzacaftor–tezacaftor–deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people 6 years and over ID6372

In development [GID-TA11430] Expected publication date: TBC

  • Project information
  • Project documents

NIHRIO BN: 27712-Vanzacaftor-Tezacaftor-Deutivacaftor-for-Cystic-Fibrosis-V1.0-AUG2023-NON-CONF.pdf (nihr.ac.uk)